Coherus BioSciences Reports Third Quarter 2020 Financial Results

NEXT STORY
Chiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
PREV STORY
Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020

author_avatar
NASDAQ Market News

iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021

author_avatar
NASDAQ Market News

New Phase 3 Data at WCPGHAN Show Long-Term Safety, Tolerability, and Treatment Benefits of Bylvay™ (odevixibat) in PFIC

author_avatar
NASDAQ Market News